Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity

Open access

Abstract

Targeting gut microbiota with synbiotics (probiotic supplements containing prebiotic components) is emerging as a promising intervention in the comprehensive nutritional approach to reducing obesity. Weight loss resulting from low-carbohydrate high-protein diets can be significant but has also been linked to potentially negative health effects due to increased bacterial fermentation of undigested protein within the colon and subsequent changes in gut microbiota composition. Correcting obesity-induced disruption of gut microbiota with synbiotics can be more effective than supplementation with probiotics alone because prebiotic components of synbiotics support the growth and survival of positive bacteria therein. The purpose of this placebo-controlled intervention clinical trial was to evaluate the effects of a synbiotic supplement on the composition, richness and diversity of gut microbiota and associations of microbial species with body composition parameters and biomarkers of obesity in human subjects participating in a weight loss program. The probiotic component of the synbiotic used in the study contained Lactobacillus acidophilus, Bifidobacterium lactis, Bifidobacterium longum, and Bifidobacterium bifidum and the prebiotic component was a galactooligosaccharide mixture. The results showed no statistically significant differences in body composition (body mass, BMI, body fat mass, body fat percentage, body lean mass, and bone mineral content) between the placebo and synbiotic groups at the end of the clinical trial (3-month intervention, 20 human subjects participating in weight loss intervention based on a low-carbohydrate, high-protein, reduced energy diet). Synbiotic supplementation increased the abundance of gut bacteria associated with positive health effects, especially Bifidobacterium and Lactobacillus, and it also appeared to increase the gut microbiota richness. A decreasing trend in the gut microbiota diversity in the placebo and synbiotic groups was observed at the end of trial, which may imply the effect of the high-protein low-carbohydrate diet used in the weight loss program. Regression analysis performed to correlate abundance of species following supplementation with body composition parameters and biomarkers of obesity found an association between a decrease over time in blood glucose and an increase in Lactobacillus abundance, particularly in the synbiotic group. However, the decrease over time in body mass, BMI, waist circumstance, and body fat mass was associated with a decrease in Bifidobacterium abundance. The results obtained support the conclusion that synbiotic supplement used in this clinical trial modulates human gut microbiota by increasing abundance of potentially beneficial microbial species.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12010222

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mean relative abundance (%) of phyla (A) and genera (B) by the treatment groups and time points.
Figure 1 Mean relative abundance (%) of phyla (A) and genera (B) by the treatment groups and time points.CC BY · PubMed Central
Figure 2 Changes in the relative microbial abundance in the gut after synbiotic intervention. * p < 0.05, ** p < 0.01, *** p < 0.001, as compared with the placebo group at the end of the trial.
Figure 2 Changes in the relative microbial abundance in the gut after synbiotic intervention. * p < 0.05, ** p < 0.01, *** p < 0.001, as compared with the placebo group at the end of the trial.CC BY · PubMed Central
Figure 3 Observed species (A), Chao1 diversity (B) and Shannon diversity (C) plotted by the treatment group and time point. The box spans the first and third quartiles. A horizontal line marks the median and the whiskers represent ±1.5 times the interquartile range. Outliers (panels A and B) are marked as individual points. Significant differences between groups were determined using the estimated marginal means analysis applied to linear mixed model, which was built with alpha diversity as the response variable, the treatment group and time points as predictor variables, and subject number as a random variable.
Figure 3 Observed species (A), Chao1 diversity (B) and Shannon diversity (C) plotted by the treatment group and time point. The box spans the first and third quartiles. A horizontal line marks the median and the whiskers represent ±1.5 times the interquartile range. Outliers (panels A and B) are marked as individual points. Significant differences between groups were determined using the estimated marginal means analysis applied to linear mixed model, which was built with alpha diversity as the response variable, the treatment group and time points as predictor variables, and subject number as a random variable.CC BY · PubMed Central
Figure 4 Principal Coordinates Analysis (PCoA) of unweighted UniFrac (A), weighted UniFrac (B) and Bray–Curtis dissimilarity data (C). The scatter plots show principal coordinate 1 (PC1) vs. principal coordinate 2 (PC2) with percentages of variation explained by the components indicated. The points are colored by the treatment group and time point.
Figure 4 Principal Coordinates Analysis (PCoA) of unweighted UniFrac (A), weighted UniFrac (B) and Bray–Curtis dissimilarity data (C). The scatter plots show principal coordinate 1 (PC1) vs. principal coordinate 2 (PC2) with percentages of variation explained by the components indicated. The points are colored by the treatment group and time point.CC BY · PubMed Central
Figure 5 Heatmap of associations between gut microbiota, body composition and metabolic parameters in the placebo (A) and synbiotic groups (B) at the end of trial. r values were calculated using Pearson’s linear correlation test; * p < 0.05, ** p < 0.01. Pearson’s r values below 0.30 or above −0.30 are not indicated. Red-brown color indicates negative correlation, blue-green color—positive correlation.
Figure 5 Heatmap of associations between gut microbiota, body composition and metabolic parameters in the placebo (A) and synbiotic groups (B) at the end of trial. r values were calculated using Pearson’s linear correlation test; * p < 0.05, ** p < 0.01. Pearson’s r values below 0.30 or above −0.30 are not indicated. Red-brown color indicates negative correlation, blue-green color—positive correlation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 57 references

Cited by

See all 348

Metadata

Authors
Sergeev, I. N., Aljutaily, T., Walton, G., & Huarte, E.
Affiliations
  • South Dakota State University (US)
  • University of Reading (GB)
Corresponding author
Sergeev, Igor N.
Venue
Nutrients
Publisher
MDPI AG
Published
2020-01-15
Volume
12
Issue
1
Pages
222
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3000290005
Cited by
331
References
57
Citations by year
2026: 33 · 2025: 73 · 2024: 64 · 2023: 53 · 2022: 61 · 2021: 30 · 2020: 17
FWCI
26.11
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • CentAUR (University of Reading) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Sanford Health/SDSU Collaborative Research Seed Grant and the South Dakota BOR R&amp;D Innovation Grant (N/A)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
Keywords
synbiotic supplementation, gut microbiota, obesity, weight loss, body composition, high-protein low-carbohydrate diet, galactooligosaccharides, prebiotics, probiotics, Lactobacillus, Bifidobacterium, microbiome diversity, blood glucose
MeSH terms
Gastrointestinal Microbiome, Adult, Bifidobacterium, Body Composition, Diet, Reducing, Female, Humans, Lactobacillus, Male, Middle Aged, Obesity, Weight Loss, Dietary Supplements, Synbiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity. https://app.cochat.ai/papers/10.3390/nu12010222
The paper
Sergeev, I. N., Aljutaily, T., Walton, G., & Huarte, E. (2020). Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity. Nutrients. https://doi.org/10.3390/nu12010222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.